Vasculitis and the Kidney

  • Giovanni M. Frascà
  • Barbara Stagni
  • Concettina Raimondi
  • Alba Vangelista
  • Vittorio Bonomini
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)


The term “vasculitis” denotes a heterogeneous group of diseases characterized by inflammation and necrosis of blood vessels and a variable clinical picture, according to the organs or tissues mainly involved by the vasculitic lesions.


Renal Biopsy Systemic Vasculitis Polyarteritis Nodosa Temporal Arteritis Fibrinoid Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A.S. Fauci, B.F. Haynes, P. Katz, The spectrum of vasculitis. Clinical, pathologic, immunologic and therapeutic considerations, Ann. Intern. Med. 89:660 (1978).PubMedGoogle Scholar
  2. 2.
    J.E. Balow, Renal vasculitis. Kidney Intern. 27:954 (1985)CrossRefGoogle Scholar
  3. 3.
    W.G. Couser, Idiopathic rapidly progressive glomerulonephritis. Am.J.Nephrol. 2:57 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    R.T. McCluskey, R. Fienberg, Vasculitis in primary vasculitides, granulomatoses and connective tissue diseases. Hum. Pathol. 14:305 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    C.L. Christian, J.S. Sergent, Vasculitis syndromes: clinical and experimental models. Am. J. Med. 61:385 (1976)PubMedCrossRefGoogle Scholar
  6. 6.
    C.G. Cochrane, Mechanisms involved in the deposition of immune complexes in tissues, J. Exp. Med. 134:75s (1971).PubMedCrossRefGoogle Scholar
  7. 7.
    G.M. Kamer, N.A. Soter, P.J. Schur, Circulating immunecomplexes in patients with necrotizing vasculitis, Clin. Immunol Immunopathol. 15:658 (1980).CrossRefGoogle Scholar
  8. 8.
    P. Ronco, P. Verroust, F. Mignon, O. Kourilsky, P. Vanhille, A. Meyrier, J-P Mery, L. Morel-Maroger, Immunopathologic studies of polyarteritis nodosa and Wegener’s granulomatosis: A report of 43 patients with 51 renal biopsies, Q.J.Med. 52:212 (1983).PubMedGoogle Scholar
  9. 9.
    E.S. Leib, C. Restivo, H.E. Paulus, Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am. J. Med. 67:941 (1979).PubMedCrossRefGoogle Scholar
  10. 10.
    A.S. Fauci, P. Katz, B.F. Haynes, S.M. Wolff, Cyclophosphamide therapy of severe systemic necrotizing vasculitis, N. Engl. J. Med. 301:245 (1979).Google Scholar
  11. 11.
    C.M. Lockwood, S. Worlledge, A. Nicholas, C. Cotton, D.K. Peters, Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange, N. Engl. J. Med. 300:524 (1979).PubMedCrossRefGoogle Scholar
  12. 12.
    I.J.M. Ten Berge, J.M. Wilmink, C.J.L.M. Meyer, J. Surachno, K.H. ten Veen, T.G. Balk, P.T.A. Schellekens, Clinical and immunological follow-up of patients with severe renal disease in Wegener’s granulomatosis. Am. J. Nephrol. 5:21 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    F.J. Van der Woude, N. Rasmussen, S. Lobatto, A. Wiik, H. Permin, L.A. van Es, M. van der Giessen, T.H. The, Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1:425 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    J. Freehally, D.C. Wheeler, J. Walls, S. Jones, C.M. Lockwood, C.O.S. Savage, A case of microscopic polyarterits associated with antineutrophil cytoplasmic antibodies (letter), Clin. Nephrol.27:214 (1987).Google Scholar
  15. 15.
    F. Nolasco, J.S. Ceuneron, B. Hartley, T lymphocyte and macrophage involvement in the glomerular lesions of microscopic polyarteritis, Proc. EPTA-EPA 22:752 (1985).Google Scholar
  16. 16.
    M.A. Weiss, J.D. Crissman, Renal biopsy findings in Wegener’s granulomatosis: segmental necrotizing glomerulonephritis with glomerular thrombosis. Hum. Pathol. 15:943 (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    R.D. Cohen, D.L. Conn, D.M. Ilstrup: Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin. Proc. 55:136 (1980).Google Scholar
  18. 18.
    A. Serra, J.S. Cameron, D.R. Turner, B. Hartley, C.S. Ogg, G.H. Neild, D.G. Williams, D. Taube, C.B. Brown, J.A. Hicks, Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome, Q.J. Med 53:181 (1984).PubMedGoogle Scholar
  19. 19.
    P.P. Frohnert, S.G. Sheps, Long-term follow-up study of periarteritis nodosa. Am. J. Med. 43:8 (1967)PubMedCrossRefGoogle Scholar
  20. 20.
    R.A. Coward, N.A.T. Hamdy, J.S. Shortland, C.B. Brown, Renal micropolyarteritis: a treatable condition, Nephrol. Dial. 1:31 (1986).Google Scholar
  21. 21.
    C.O. Savage, C.G. Winearls, D.J. Evans, A.J. Rees, C.M. Loockwood, Immunosuppressive treatment of 34 patients with microscopic polyarteritis, Proc EDTA-ERA 22:720 (1985)Google Scholar
  22. 22.
    D. Ouzan, P.J. Tremisi, E. Strauss, P. Chossegros, J. Pasquier, P. Zech, P. Dujardin, J. Delmont, C. Trepo, Superiority of plasmaexchange combined with vidarabin over classic therapy in the management of polyarteritis nodosa associated with hepatitis B virus, Plasma Ther. Trangfus Technol 6:487 (1985).Google Scholar
  23. 23.
    E.W. Walton, Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br. Med. J. 2:265 (1958).PubMedCrossRefGoogle Scholar
  24. 24.
    M.A. Aldo, M.D. Benson, F.R. Comerford, A.S. Cohen, Treatment of Wegener’s granulomatosis with immunosuppressive agents. Arch. Intern. Med. 126:298 (1970).PubMedCrossRefGoogle Scholar
  25. 25.
    A.S. Fauci, B. F. Haynes, P. Katz, S. M. Wolff, Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years, Ann. Intern. Med. 98:76 (1983).PubMedGoogle Scholar
  26. 26.
    F. Chenais, J. L. Debru, L. Baret, J. Faure, J. M. Chalopin, G. Rifle, Plasmaexchange in the treatment of Polyarteritis Nodosa, in: “Plasmaexchange”, Sieberth HG, ed., F.K. Schattauer, Stuttgart (1980), pag.285.Google Scholar
  27. 27.
    A.J. Pinching, C.M. Lockwood, B.A. Pussell, A.J. Rees, P. Sweny, D.J. Evans, N. Bowley, D.K. Peters, Wegener’s granulomatosis: Observations on 18 patients with severe renal disease, Q. J. Med. 208:435 (1983).Google Scholar
  28. 28.
    M.R. Garovoy, P. Gailiunas, C.B. Carpenter, G.J. Busch, Immunologic monitoring of transplant rejection: correlation of in vitro assays with morphologic changes on transplant biopsy. Nephron 22:208 (1978).PubMedCrossRefGoogle Scholar
  29. 29.
    R. Roy, J.G. Lachance, Y. Fradet, J. Hebert, Characterization of lymphocytotoxic antibodies in renal transplantation. Transplantation 31:31 (1981).PubMedCrossRefGoogle Scholar
  30. 30.
    A. Magil, J. Rubin, L. Ladewig, M. Johnson, M.B. Goldstein, R.A. Bear, Renal biopsy in acute allograft rejection. Nephron 26:180 (1980).PubMedCrossRefGoogle Scholar
  31. 31.
    A. Vangelista, G.M. Frascè, A. Nanni Costa, S. Stefoni, V. Bonomini, Value of plasmaexchange in renal transplant rejection induced by specific anti-HLA antibodies. Trans. Am. Soc. Artif. Intern. Organs 28:599 (1982).PubMedGoogle Scholar
  32. 32.
    V. Bonomini, A. Vangelista, G.M. Frascè, A. Di Felice, G. Liviano D’Arcangelo, Effect of plasmapheresis in renal transplant rejection. A controlled study. Trans. Am. Soc. Artif. Intern Organs 31:698 (1985).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Giovanni M. Frascà
    • 1
  • Barbara Stagni
    • 1
  • Concettina Raimondi
    • 1
  • Alba Vangelista
    • 1
  • Vittorio Bonomini
    • 1
  1. 1.Institute of NephrologySt. Orsola Univ. HospitalBolognaItaly

Personalised recommendations